|22nd October 2015
At Blue Latitude Health, our strategic planning, customer experience, and creative services teams work together to ensure that our clients’ campaigns launch without a hitch. We work across many different therapy areas, helping brands to position, launch, and support their campaigns at global, regional, and local levels. Localising global and regional campaigns is a challenge all global organisations face. However, for healthcare brands, it can be even more challenging because local regulations and healthcare systems can be so wildly variable and complicated.
A lot of work goes into a regional marketing strategy, but without coherent execution at the local level, the campaign loses impact. Account Director Dolan Desai talks us through the five core considerations that will allow you to maximise impact across a region through coherent execution:
Before worrying about country-level assets, you must be crystal clear on what you want those assets to say. Not taking the time to establish and support the regional messaging before rolling out locally can lead to unfocussed and disjointed local activity. Once your messaging is clear, meaning you know what you want to say, and to whom, then you’re ready to move on to the next step: the messaging framework.
|11th December 2018
Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face when making treatment decisions, and why patients need to be treated with more efficacious drugs earlier on.
|10th December 2018
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging markets.
|3rd December 2018
Multi-award-winning advocate and patient engagement champion Trishna Bharadia gives a valuable insight into life with multiple sclerosis. She explains how treatment has changed, how our healthcare systems and pharma can unite to improve quality of life for MS patients today, and why her diagnosis isn’t stopping her achieving her goals.